Boswellia Phytosome

• SKU: SF819
• Product form: Capsule
• Size: 60 Vegetarian Capsules
• Availability: In Stock

Boswellia bound to phospholipids for enhanced absorption

• Three- to seven-fold higher levels of boswellic acids in plasma due to phytosome technology
• Clinical trials support the efficacy of boswellia phytosome (Casperome)
• Supports a healthy balance of inflammatory cytokines in the respiratory tract, GI tract, brain, and musculoskeletal system
• Contains a full spectrum of boswellic acids

Product Description

Supplementation with boswellia phytosome - boswellia bound to phospholipids (Casperome) - results in significantly higher plasma levels of boswellic acids compared to non-complexed boswellia. Plasma levels were three- to seven-fold higher for the phytosome, depending on which boswellic acid was analyzed. The phytosome results in higher tissue levels as well - from three- to 35-fold higher levels, depending on the tissue and the boswellic acid analyzed.

Boswellia phytosome has been clinically studied for its effect on healthy cytokine balance. It has been shown to be supportive for the respiratory tract, GI tract, and musculoskeletal system - joints, muscles, and tendons. Boswellia also helps balance the cerebral inflammatory response to protect brain tissue.

Ingredients

One Capsule Contains:
Indian Frankincense Phytosome (Boswellia serrata (oleo-gum-resin) / Phospholipid complex) 350 mg

Other Ingredients: Hypromellose (derived from cellulose) capsule, Microcrystalline Cellulose, Leucine.
Contains ingredient derived from soy (phytosome).

This product uses Indena S.p.A.'s Indian frankincense phytosome (Casperome). Casperome is a registered trademark of Indena S.p.A.

Suggested Use

Take 1 capsule two times daily or as recommended by your health-care practitioner.

Warnings

ALLERGY
This product is contraindicated in an individual with a history of hypersensitivity to any of its ingredients.

PREGNANCY
If pregnant, consult your health-care practitioner before using this product.

INTERACTIONS
There are no known adverse interactions or contraindications at publication date.